← All trials
NCT07093268
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 15, 2025
- Primary completion
- Jun 15, 2026
- Completion date
- Jan 15, 2027
- First posted
- Jul 30, 2025
- Last posted
- Jul 30, 2025
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Brain Trust BioLead sponsor
- Flinders UniversityOfficial
- Sunshine Coast University, AustraliaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.